Lung Tumors
Neutron therapy is appropriate for the following non-small-cell histologies:
- Squamous cell carcinoma
- Large cell carcinoma
- Adenocarcinoma
Patients who may benefit from neutron therapy include:
- Patients whose primary tumor is a Stage T3 or T4, unresectable carcinoma including one of the histologies listed above.
- Patients with N2A, N2B or N3 nodal disease.
- Patients with a localized lung tumor that has metastasized from a neutron-sensitive tumor in another part of the body.
|